a public good project by the
Synthesis
Company
of California

© 2026

Dominique Baeten | doi.page

0 works0 citations0 h-index

Dominique Baeten

Amsterdam University Medical Centers(NL)University of Amsterdam(NL)Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)

Publications by Year

Research Areas

Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis, Autoimmune and Inflammatory Disorders Research, Systemic Lupus Erythematosus Research

Most-Cited Works

→ Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis(2015)988 cited
→ Spondyloarthritis(2011)740 cited
→ Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial(2013)586 cited
→ Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis(2004)461 cited
→ Systematic validation of specific phenotypic markers for in vitro polarized human macrophages(2011)413 cited
→ Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance(2007)363 cited

→ Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study(2018)

363 cited

→ Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy(2002)355 cited

Arthritis 2 Spondyloarthritis(2011)

→ Myelin oligodendrocyte glycoprotein–specific T and B cells cooperate to induce a Devic-like disease in mice(2006)333 cited